Researchers have been excited about the medication , a novel dual agonist showing remarkable data in clinical trials for weight loss . It functions by targeting two systems: GLP-1 and GIP, that , when https://matteobqae275423.getblogs.net/73344377/this-new-prospect-for-size-loss